Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study.

D S Fedson1, M P Harward, R A Reid

  • 1Department of Medicine, University of Virginia School of Medicine, Charlottesville.

JAMA
|September 5, 1990
PubMed
Summary

Hospital-based pneumococcal immunization is useful for preventing pneumonia readmissions in elderly patients. Vaccinating around 100 discharged patients can prevent readmissions and save costs compared to hospital care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

WORKSHOP ON TEXTURE IN ELECTRONIC APPLICATIONS Gaithersburg, MD October 10-11, 2000.

Journal of research of the National Institute of Standards and Technology·2016
Same author

Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide.

BJOG : an international journal of obstetrics and gynaecology·2015
Same author

Improving surveillance of the impact of influenza and its prevention in Canada.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Random and Non-Random Coincidence Between Luteinizing Hormone Peaks and Follicle-Stimulating Hormone, Alpha Subunit, Prolactin and Gonadotropin-Releasing Hormone ulsations.

Journal of neuroendocrinology·2009
Same author

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007

Area of Science:

  • Epidemiology
  • Preventive Medicine
  • Health Economics

Background:

  • Pneumonia is a significant cause of hospital readmission, particularly among the elderly.
  • Identifying high-risk patients after hospital discharge is crucial for preventive strategies.
  • Previous hospitalizations often indicate underlying high-risk conditions for pneumonia.

Purpose of the Study:

  • To evaluate the effectiveness of hospital-based pneumococcal immunization.
  • To assess the potential for preventing pneumonia readmissions through vaccination.
  • To analyze the cost-effectiveness of pneumococcal vaccination in discharged patients.

Main Methods:

  • Retrospective analysis of linked hospital discharge records for Medicare enrollees in Virginia.
  • Cohort study to determine readmission rates for pneumonia within 5 years.

Related Experiment Videos

  • Calculation of vaccination costs versus hospital care costs for readmissions.
  • Main Results:

    • 61-62% of pneumonia patients had prior discharges within 4 years.
    • 87% of these had recognized high-risk conditions during previous admissions.
    • Discharged patients had a 6-9% probability of 5-year pneumonia readmission.
    • Vaccinating ~100 patients could prevent readmissions.
    • Vaccination costs are one-third of readmission hospital care costs.

    Conclusions:

    • Hospital-based pneumococcal immunization is an effective preventive strategy.
    • Vaccination offers a cost-effective approach to reduce pneumonia readmissions.
    • Supports recommendations for vaccinating elderly hospital discharge patients.